Initial reactions from the sector’s European organisations are fairly positive about the 11 March proposal of a Critical Medicines Act, although they are calling for harmonisation of medicine stockpiling policies (see EUROPE B13597A18).
The European Federation of Pharmaceutical Industries and Associations(EFPIA) believes that the regulation needs to “go further” and “provide an effective response to fragmented national contingency stock requirements that disrupt the functionality of...